Advanced search

1674 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Artists from Universal Music Group are heading back to TikTok as new licensing deal reached	05-02	AQ
Transcript : Universal Music Group N.V., Q1 2024 Earnings Call, May 02, 2024	05-02
Transcript : Novo Nordisk A/S, Q1 2024 Earnings Call, May 02, 2024	05-02
TikTok to Welcome Back Universal Music Artists After New Licensing Agreement -- 2nd Update	05-02	DJ
Inventiva : Présentation corporate avril 2024	04-30	PU
Transcript : Gilead Sciences, Inc., Q1 2024 Earnings Call, Apr 25, 2024	04-25
Transcript : Ally Financial Inc., Q1 2024 Earnings Call, Apr 18, 2024	04-18
Transcript : CarMax, Inc., Q4 2024 Earnings Call, Apr 11, 2024	04-11
Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024	03-28
Transcript : Inventiva S.A. - Special Call	03-19
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D	03-18	GL
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D	03-18	AQ
Transcript : Madrigal Pharmaceuticals, Inc. - Special Call	03-14
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell	03-06	AQ
Inventiva : Corporate Presentation March 2024	03-01	PU
Citi Trends Announces Refresh of Board of Directors	02-29	BU
UMG targets 250 mln euros in savings by 2026, flags job cuts	02-28	RE
Transcript : Universal Music Group N.V., Q4 2023 Earnings Call, Feb 28, 2024	02-28
Transcript : KBR, Inc., Q4 2023 Earnings Call, Feb 20, 2024	02-20
Transcript : Capital One Financial Corporation, Discover Financial Services - M&A Call	02-20
ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe	02-15	AQ
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe	02-14	BU
Transcript : CoinShares International Limited, Q4 2023 Earnings Call, Feb 13, 2024	02-13
Transcript : Amgen Inc., Q4 2023 Earnings Call, Feb 06, 2024	02-06
Transcript : Novo Nordisk A/S, 2023 Earnings Call, Jan 31, 2024	01-31
Transcript : Discover Financial Services, Q4 2023 Earnings Call, Jan 18, 2024	01-18
Hudson Pacific Properties, Inc. Announces Board Changes	01-17	CI
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference	01-04	CI
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference	01-04	AQ
NeuroBo to Participate in Industry and Investor Conferences in January	01-02	PR
Transcript : CarMax, Inc., Q3 2024 Earnings Call, Dec 21, 2023	12-21
NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split	12-19	PR
Transcript : Westpac Banking Corporation - Shareholder/Analyst Call	12-13
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call	12-13
Barclays Recognizes 81 New Managing Directors in the Corporate and Investment Bank	12-07	BU
Hudson Pacific Appoints Michael Nash to Board of Directors	12-07	BU
Hudson Pacific Properties, Inc. Announces Board Changes	12-07	CI
Transcript : Vivoryon Therapeutics N.V., Q3 2023 Earnings Call, Dec 06, 2023	12-06
CAN-FITE'S NAMODENOSON FOR THE TREATMENT OF PANCREATIC CANCER PATIENTS, PROGRESS IN CLINICAL DEVELOPMENT	12-05	AQ
Transcript : Zealand Pharma A/S - Special Call	12-05
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH	12-04	GL
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH	12-04	AQ
NEUROBO TO PARTICIPATE IN INVESTOR CONFERENCES IN DECEMBER	12-04	AQ
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development	12-04	BU
NeuroBo to Participate in Investor Conferences in December	12-01	PR
Madrigal Pharmaceuticals Presents New Data from the Phase 3 MAESTRO-NASH Trial Demonstrating Broad Treatment Effects of Resmetirom on Noninvasive Measures of Liver Health	11-10	AQ
Transcript : Zealand Pharma A/S, Q3 2023 Earnings Call, Nov 09, 2023	11-09
Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023	11-06	GL
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results	11-06	AQ
Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLD	11-03	AQ

No results for this search

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer